SecBot SecBot

TECH

BIO-TECHNE Corp
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. MN· CIK 0000842023 Biotech & Drug Discovery
$72.78 −0.02 (−0.03%)
Nov 16 4:00 PM ET · prev $72.80
Market cap
$11.4B
Large cap
Median target
$73.00
+0% · range $50.00–73.00
1 year
+24.2%
from $58.61 · Nov 17
30 days
+0.3%
from $72.57
52-week range
$43.30–72.84
−0% from high · low May 15
Avg volume 20D
2.90M
shares / day
Short interest
7.70M
≈4.9% of shares · +2.0%
Days to cover
2.7
at average volume
Insider net
$0
no open-market trades · since Aug 15
New fund stakes
16
Q2 2026 13F · 5 exits
Filing reports
10
analyzed by SecBot
Congress trades
4
disclosed
SecBot read MIXED 8 reports · 90 days
Balance 1 bearish · 2 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 7/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Aug 15. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 49 added (16 new), 52 trimmed or exited. Largest new: Millennium Management $69.9M, Tudor Investment Et Al $66.6M.

  • Short sellersSTEADY

    Short interest +2.0% to 7.70M shares. 2.7 days to cover, ≈4.9% of shares.

  • TrendUPTREND

    0% above its 50-day average. New closing high $72.84 on Nov 12.

Who's buying

13F· Q2 2026
16
new positions
5
exits
$487.0M
in new stakes
FundMoveSharesValue
FMR LLCADD12,794,784$904.0M
GOLDMAN SACHS GROUP INCDOUBLED7,343,324$518.8M
MORGAN STANLEYTRIM6,374,717$450.4M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/TRIM2,746,462$194.0M
JPMORGAN CHASE & COADD1,862,805$132.6M
AmundiDOUBLED1,827,241$129.1M
MAVERICK CAPITAL LTDTRIM1,535,610$108.5M
Bank of New York Mellon CorpTRIM1,278,196$90.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Aug 2026
12-month targets · 10 analysts

Price is inside the target range. Median implies +0%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Aug 13, 2026Wells Fargo
DOWNGRADE
DOWNGRADEEqual-Weight
Jul 9, 2026RBC Capital
DOWNGRADE
DOWNGRADESector Perform
Jun 30, 2026TD Cowen
DOWNGRADE
DOWNGRADEHold
Jun 30, 2026Benchmark
DOWNGRADE
DOWNGRADEHold
Jun 29, 2026Citigroup
DOWNGRADE
DOWNGRADENeutral
Jun 26, 2026Stephens & Co.
DOWNGRADE
DOWNGRADEEqual-Weight

Washington

Corporate Lobbying

8 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
open-market buys or sells · since Aug 15
DateInsiderTypeValue
Nov 1, 2026
Hippel James
CFO
Nov 1, 2026
EXERCISE11,545 sh
Nov 1, 2026
Kelderman Kim
Chief Executive Officer
Nov 1, 2026
TAX W/H$173.3K
Nov 1, 2026
Hippel James
CFO
Nov 1, 2026
TAX W/H$370.3K
Oct 29, 2026
BAUMGARTNER ROBERT V
Director
Oct 29, 2026
AWARD2,750 sh
Oct 29, 2026
Bushman Julie L
Director
Oct 29, 2026
AWARD2,750 sh
Oct 29, 2026
Klimovsky Judith V.
Director
Oct 29, 2026
AWARD2,750 sh
Oct 29, 2026
Herr Amy E.
Director
Oct 29, 2026
AWARD2,750 sh
Oct 29, 2026
Vessey Rupert
Director
Oct 29, 2026
AWARD2,750 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
TECH trades disclosed by members of Congress, with disclosure delay.
2 members · 1 buys / 3 sells
DateMemberType AmountDisclosed
May 15, 2026 Ro KhannaDHouse Spouse account · Bio-Techne Corp BUY $1K–$15K Jun 9, 2026 +25d
Apr 8, 2026 April McClain DelaneyDHouse Child account · Bio-Techne Corp SELL $1K–$15K May 6, 2026 +28d
Mar 26, 2026 April McClain DelaneyDHouse Child account · Bio-Techne Corp SELL $1K–$15K Apr 6, 2026 +11d
Feb 24, 2026 April McClain DelaneyDHouse Child account · Bio-Techne Corp SELL $1K–$15K Mar 10, 2026 +14d

Short side

FINRA· Oct 30, 2026
7,703,626
shares short
+2.0%
vs prior settlement
2.7
days to cover
≈4.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

10 filings · 2 press releases · 4 bullish · 1 bearish · 5 neutral
All TECH filing & press-release reports (12)